HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock
HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ:SPPI), with a price target of $10. The analyst projects revenues of $170…
Spectrum Pharmaceuticals: Q4 Earnings Insights
Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
The Daily Biotech Pulse: AbbVie’s Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb’s Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.
Spectrum Pharma Highlights Poziotinib Data In Treatment-Naïve Lung Cancer Setting
Spectrum Pharmaceuticals Inc (NASDAQ: SPPI) announced the presentation of
Spectrum Pharmaceuticals Presents Positive Data For Poziotinib In First-line NSCLC Patients With HER2 Exon 20 Insertion Mutations
Spectrum Pharmaceuticals (NASDAQ:SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of safety and efficacy results from Cohort 4 of the ZENITH20 clinical
31 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Cidara Therapeutics (NASDAQ:CDTX) stock moved upwards by 14.1% to $0.91 during Thursday's after-market session. The company's market cap stands at $60.6 million.